VIDA VENTURES ADVISORS, LLC Holdings

VIDA VENTURES ADVISORS, LLC is an investment fund managing more than 111.42M US dollars. The largest holdings include Dyne Therapeutics, Kinnate Biopharma and Allogene Therapeutics. In Q4 2021 the fund bought assets of total value of 14.06M US dollars and sold assets of total value of 7.59M US dollars.

$111.42M

portfolio value

+7.65%

quarter

-64.08%

1 year

VIDA VENTURES ADVISORS, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q2 2021	87326000	3489000
Q4 2021	14058000	7585000

VIDA VENTURES ADVISORS, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Dyne Therapeutics, Inc. Portfolio share: 25.30% Portfolio value: 28.19M Avg. open price: N/A Current price: $11.53 P/L: N/A Sold -25.00% shares Q3 2022	share	25.30%	28.19M	N/A	$11.53	N/A	Sold -25.00% shares Q3 2022
Biotechnology Kinnate Biopharma Inc. Portfolio share: 23.68% Portfolio value: 26.38M Avg. open price: $39.78 Current price: $7.14 P/L: -82.05% Sold -19.64% shares Q3 2022	share	23.68%	26.38M	$39.78	$7.14	-82.05%	Sold -19.64% shares Q3 2022
Biotechnology Allogene Therapeutics, Inc. Portfolio share: 17.43% Portfolio value: 19.42M Avg. open price: N/A Current price: $9.52 P/L: N/A N/A Q3 2020	share	17.43%	19.42M	N/A	$9.52	N/A	N/A Q3 2020
Biotechnology Centessa Pharmaceuticals plc Portfolio share: 14.18% Portfolio value: 15.80M Avg. open price: N/A Current price: $3.81 P/L: N/A N/A Q2 2021	share	14.18%	15.80M	N/A	$3.81	N/A	N/A Q2 2021
Biotechnology Kronos Bio, Inc. Portfolio share: 8.31% Portfolio value: 9.26M Avg. open price: N/A Current price: $1.79 P/L: N/A N/A Q4 2020	share	8.31%	9.26M	N/A	$1.79	N/A	N/A Q4 2020
Biotechnology Praxis Precision Medicines, Inc. Portfolio share: 5.99% Portfolio value: 6.67M Avg. open price: N/A Current price: $2.19 P/L: N/A N/A Q4 2020	share	5.99%	6.67M	N/A	$2.19	N/A	N/A Q4 2020
Biotechnology LianBio Portfolio share: 4.10% Portfolio value: 4.56M Avg. open price: N/A Current price: $1.47 P/L: N/A N/A Q4 2021	share	4.10%	4.56M	N/A	$1.47	N/A	N/A Q4 2021
Biotechnology Homology Medicines, Inc. Portfolio share: 1.01% Portfolio value: 1.12M Avg. open price: N/A Current price: $1.47 P/L: N/A Sold -9.67% shares Q3 2022	share	1.01%	1.12M	N/A	$1.47	N/A	Sold -9.67% shares Q3 2022

Showing TOP 8 VIDA VENTURES ADVISORS's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of VIDA VENTURES ADVISORS, LLC?

The biggest position of the VIDA VENTURES ADVISORS, LLC is Dyne Therapeutics, Inc. (DYN) with 25.3% portfolio share worth of 28.19M US dollars.

Top 5 VIDA VENTURES ADVISORS's holdings represent 88.91% of the portfolio:

Dyne Therapeutics, Inc. (DYN) – 25.3%
Kinnate Biopharma Inc. (KNTE) – 23.68%
Allogene Therapeutics, Inc. (ALLO) – 17.43%
Centessa Pharmaceuticals plc (CNTA) – 14.18%
Kronos Bio, Inc. (KRON) – 8.31%

Who is the portfolio manager of VIDA VENTURES ADVISORS, LLC?

The portfolio manager of the VIDA VENTURES ADVISORS, LLC is .

What is the total asset value of the VIDA VENTURES ADVISORS, LLC portfolio?

VIDA VENTURES ADVISORS, LLC total asset value (portfolio value) is 111.42M US dollars.

Who is ?

is the portfolio manager of the VIDA VENTURES ADVISORS, LLC.

What is (VIDA VENTURES ADVISORS, LLC) fund performance?

VIDA VENTURES ADVISORS's quarterly performance is +7.65%, annualy -64.08%.

What is the VIDA VENTURES ADVISORS, LLC CIK?

VIDA VENTURES ADVISORS's Central Index Key is 0001831423 .